The AVOCAT study: Bicalutamide monotherapy versus combined bicalutamide plus dutasteride therapy for patients with locally advanced or metastatic carcinoma of the prostate-a long-term follow-up comparison and quality of life analysis.
about
The AVOCAT study: Bicalutamide monotherapy versus combined bicalutamide plus dutasteride therapy for patients with locally advanced or metastatic carcinoma of the prostate-a long-term follow-up comparison and quality of life analysis.
description
2016 nî lūn-bûn
@nan
2016 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
The AVOCAT study: Bicalutamide ...... and quality of life analysis.
@ast
The AVOCAT study: Bicalutamide ...... and quality of life analysis.
@en
The AVOCAT study: Bicalutamide ...... and quality of life analysis.
@nl
type
label
The AVOCAT study: Bicalutamide ...... and quality of life analysis.
@ast
The AVOCAT study: Bicalutamide ...... and quality of life analysis.
@en
The AVOCAT study: Bicalutamide ...... and quality of life analysis.
@nl
prefLabel
The AVOCAT study: Bicalutamide ...... and quality of life analysis.
@ast
The AVOCAT study: Bicalutamide ...... and quality of life analysis.
@en
The AVOCAT study: Bicalutamide ...... and quality of life analysis.
@nl
P2093
P2860
P1433
P1476
The AVOCAT study: Bicalutamide ...... n and quality of life analysis
@en
P2093
Arno D H Geboers
Erik P M Roos
Geert A H J Smits
Henk Vergunst
Jos L Bruins
Peter F A Mulders
Peter L M Vijverberg
Siebren Dijkstra
P2860
P2888
P356
10.1186/S40064-016-2280-8
P50
P577
2016-05-17T00:00:00Z
P6179
1026102438